CClinicalTrials.gg
Active, not recruitingNCT06846840Updated Feb 26, 2025

Ketone Esters and Metabolism During Recovery from Endurance Exercise

An interventional study of Ketone ester and Placebo in Exercise and Metabolism, sponsored by University of Bath. Active, not recruiting at 1 site in United Kingdom. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-02-26.

Sponsored by University of Bath · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Nov 2024, registered Feb 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
18
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Infusion of beta-hydroxybutyrate can suppress endogenous glucose production, which may result in increased net liver glycogen storage. If ketone esters exert similar effects, then the increase in liver glycogen storage may have implication for recovery from exercise and subsequent exercise performance.

The aim of this study is to assess the effects of ketone esters ingested during recovery from exercise, on metabolism and subsequent exercise capacity.

02

Conditions studied

  • Exercise
  • Metabolism
03

In context

Lead sponsor

University of Bath is the lead sponsor of 91 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • VO2max ≥ 45mL.kg-1.min-1
  • Weekly aerobic training > 3hours.
  • 2years running experience.
  • BMI \< 30kg/m2

Exclusion criteria

Exclusion Criteria:

  • \<18yrs or >60yrs of age
  • Habitual smoker within last 5 years.
  • History of uncontrollable metabolic or respiratory disease.
  • Currently taking medication, following a low carbohydrate or ketogenic diet, or consuming nutritional ketone supplements.
  • History of Irritable Bowel Syndrome
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
18 participants (actual)

Study arms

  • Placebo comparator
    PLACEBO

    Energy matched placebo containing medium-chain triglycerides and bitter taste

    Dietary Supplement: Placebo

  • Experimental
    KETONE

    Beta-hydroxybutyrate monoester

    Dietary Supplement: Ketone ester

Interventions

  • Dietary supplementKetone ester

    0.29 g per kilogram body mass per hour of ketone monoester (R)-3-hydroxybutyrate (R)-3-hydroxybutyl

  • Dietary supplementPlacebo

    Medium chain triglycerides and bitter tastant (Bitrex)

06

What researchers measure

Primary outcomes

  1. Glucose concentrations

    Blood glucose concentrations during the recovery period (240 minutes)

    Time frame: 240 minutes

Secondary outcomes

  1. Non-oxidative fate of ingested sucrose

    Non-oxidative fate of ingested glucose measured by appearance of 13C on breath CO2 from high 13C sucrose ingested during recovery

    Time frame: 240 minutes

  2. Exercise capacity

    Time to exhaustion running at 70% of maximal aerobic capacity after the recovery period

    Time frame: 240 minutes

Other outcomes

  1. Blood beta-hydroxybutyrate concentrations

    Blood beta-hydroxybutyrate concentrations throughout the 240 minute recovery

    Time frame: 240 minutes

  2. Urinary urea

    Urea in urine, determined by urea concentration multiplied by total urine output during the 240 minutes of recovery

    Time frame: 240 minutes

  3. Blood lactate concentrations

    Blood lactate concentrations during 240 minutes of recovery

    Time frame: 240 minutes

  4. Plasma insulin concentrations

    Plasma insulin concentrations during 240 minutes of recovery

    Time frame: 240 minutes

  5. Blood pH

    Blood pH during 240 minutes of recovery

    Time frame: 240 minutes

  6. Blood bicarbonate

    Blood bicarbonate concentrations during 240 minutes of recovery

    Time frame: 240 minutes

07

Study locations

1 site
  • University of Bath
    Bath, BA2 7AY, United Kingdom
08

References and documents

Individual participant data

Plan to share: Yes — Plan is to share individual deidentied data on a public repository such as Mendeleydata.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06846840
Lead sponsor
University of Bath
Responsible party
Javier Gonzalez (Professor of Nutrition and Metabolism, University of Bath) — Principal investigator
First posted
Feb 26, 2025
Start date
Nov 1, 2024
Primary completion
Feb 17, 2025
Completion
May 1, 2025 (estimated)
Last update
Feb 26, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion